Clinical Trial Update: Effects of IGF-I in HIV Metabolic Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating insulin-like growth factor-1 (IGF-1) for HIV-associated lipodystrophy/metabolic disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Lipodystrophy

Drugs mentioned

• IGF-1 (insulin-like growth factor 1)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: HIV Lipodystrophy | Phase 1 | Status: TERMINATED